$AMRX Cashflow Statement | Understand Stock

$AMRX

$21.44 +$0.42 (2.0%) Close

$AMRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Gain from reduction of tax receivable agreement liability
Depreciation and amortization
Amortization of Levothyroxine Transition Agreement asset
Unrealized foreign currency (gain) loss
Amortization of debt issuance costs
Amortization of debt issuance costs and discount
Reclassification of cash flow hedge
Loss on refinancing
Gain on sale of international businesses, net
Intangible asset impairment charges
Non-cash restructuring and asset-related (benefit) charges
Deferred tax provision
Change in fair value of contingent consideration
Stock-based compensation
Inventory provision
Insurance recoveries for property and equipment losses
Non-cash property losses
Other operating charges and credits, net

Changes in assets and liabilities:
Trade accounts receivable, net
Inventories
Prepaid expenses, other current assets and other assets
Related party receivables
Accounts payable, accrued expenses and other liabilities
Related party payables
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Acquisition of intangible assets
Deposits for future acquisition of property, plant, and equipment
Acquisitions of business
Proceeds from insurance recoveries for property and equipment losses
Proceeds from sale of international businesses, net of cash sold
Proceeds from sale of property, plant, equipment and other
Proceeds from sale of subsidiary
Net cash used in investing activities

Cash flows from financing activities:
Payments of principal on debt, financing leases and other
Proceeds from issuance of debt
Payments of principal on debt, revolving credit facility, financing leases and other
Payments of deferred financing, refinancing costs and debt extinguishment costs
Borrowings on revolving credit facility
Proceeds from exercise of stock options
Employee payroll tax withholding on restricted stock unit and performance stock unit vesting
Payments of deferred consideration for acquisitions - related party
Acquisition of redeemable non-controlling interests
Distribution of earnings to and acquisition of non-controlling interest
Tax and other distributions to non-controlling interests
Payments of principal on financing lease - related party
Payment of principal on notes payable - related party
Proceeds from alliance party
Net cash used in financing activities

Effect of foreign exchange rate on cash
Net increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash - beginning of period
Cash, cash equivalents, and restricted cash - end of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid, net for income taxes
Supplemental disclosure of non-cash investing and financing activity:
Notes payable for acquisitions - related party
Deferred consideration for acquisition - related party
Contingent consideration for acquisition
Contingent consideration for acquisition - related party
Payable for acquisition of product rights and licenses
Loan for land purchase - related party
Cash and cash equivalents - end of period
Restricted cash - end of period
Long-term restricted cash included in other assets - end of period

Comments